ARTICLE | Company News
Weill Cornell Medical College, J&J deal
January 6, 2017 10:31 PM UTC
Johnson & Johnson’s Janssen Biotech Inc. unit and Weill Cornell partnered to identify therapies for treatment-resistant prostate cancer. Janssen has an exclusive option to negotiate for rights to any ...